188 related articles for article (PubMed ID: 29314035)
1. Economic evaluation of floseal compared to nasal packing for the management of anterior epistaxis.
Le A; Thavorn K; Lasso A; Kilty SJ
Laryngoscope; 2018 Aug; 128(8):1778-1782. PubMed ID: 29314035
[TBL] [Abstract][Full Text] [Related]
2. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
Murray S; Mendez A; Hopkins A; El-Hakim H; Jeffery CC; Côté DWJ
J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):3. PubMed ID: 29310703
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.
Mathiasen RA; Cruz RM
Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662
[TBL] [Abstract][Full Text] [Related]
4. The utility of FloSeal haemostatic agent in the management of epistaxis.
Khan MK; Reda El Badawey M; Powell J; Idris M
J Laryngol Otol; 2015 Apr; 129(4):353-7. PubMed ID: 25776997
[TBL] [Abstract][Full Text] [Related]
5. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
6. A Clinical Decision Analysis for Use of Antibiotic Prophylaxis for Nonabsorbable Nasal Packing.
Maul X; Dincer BC; Wu AW; Thamboo AV; Higgins TS; Scangas GA; Oliveira K; Ho AS; Mallen-St Clair J; Walgama E
Otolaryngol Head Neck Surg; 2021 Nov; 165(5):647-654. PubMed ID: 33588621
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis.
Rudmik L; Leung R
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):802-8. PubMed ID: 25123233
[TBL] [Abstract][Full Text] [Related]
8. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial.
Côté D; Barber B; Diamond C; Wright E
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):304-8. PubMed ID: 20470677
[TBL] [Abstract][Full Text] [Related]
9. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
Makhija D; Rock M; Xiong Y; Epstein JD; Arnold MR; Lattouf OM; Calcaterra D
J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
[TBL] [Abstract][Full Text] [Related]
10. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.
Lau AS; Upile NS; Lazarova L; Swift AC
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2579-84. PubMed ID: 26920703
[TBL] [Abstract][Full Text] [Related]
12. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
13. The use of FloSeal haemostatic sealant in the management of epistaxis: a prospective clinical study and literature review.
Wakelam OC; Dimitriadis PA; Stephens J
Ann R Coll Surg Engl; 2017 Jan; 99(1):28-30. PubMed ID: 27490981
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.
Herring W; Pearson I; Purser M; Nakhaipour HR; Haiderali A; Wolowacz S; Jayasundara K
Pharmacoeconomics; 2016 Jan; 34(1):77-90. PubMed ID: 26518293
[TBL] [Abstract][Full Text] [Related]
15. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis.
Scangas GA; Remenschneider AK; Su BM; Shrime MG; Metson R
Laryngoscope; 2017 Jan; 127(1):29-37. PubMed ID: 27440486
[TBL] [Abstract][Full Text] [Related]
16. Intranasal packs and haemostatic agents for the management of adult epistaxis: systematic review.
Iqbal IZ; Jones GH; Dawe N; Mamais C; Smith ME; Williams RJ; Kuhn I; Carrie S
J Laryngol Otol; 2017 Dec; 131(12):1065-1092. PubMed ID: 29280695
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of endoscopic sphenopalatine artery ligation versus nasal packing as first-line treatment for posterior epistaxis.
Dedhia RC; Desai SS; Smith KJ; Lee S; Schaitkin BM; Snyderman CH; Wang EW
Int Forum Allergy Rhinol; 2013 Jul; 3(7):563-6. PubMed ID: 23307796
[TBL] [Abstract][Full Text] [Related]
18. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
Teti VP; Akdagli S; Most SP
JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
